Ingenix
Ingenix Raises €13M Seed Extension for AI Drug Development
Ingenix announced €13M in Seed Extension financing on June 3, 2026. Ingenix raised a €13 million seed extension led by Sofinnova Partners to scale its Biological Reasoning Engine, built on its Modality Fusion architecture.
Round details
The financing includes backing from Sofinnova Partners, Inovo VC, OTB VC. The company did not publish a valuation with the announcement.
- Round: Seed Extension
- Capital announced: €13M
- Headquarters: Warsaw
How the company plans to use the capital
Ingenix said the funding will scale development of its Biological Reasoning Engine and broaden its work with pharma and biotech partners through the Qualified Access Program, which launched on the announcement date.
Why this matters for GTM teams
Sofinnova Partners led the round, with Inovo VC and OTB VC participating, and Ingenix describes its Biological Reasoning Engine as built for translational and clinical R&D decisions.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Ingenix seed extension announcement.
Company Info
Investors (3)
Share
Related Reports
Infisical Raises $40M Series B for AI Agent Security Infrastructure
Infisical raised a $40 million Series B at a $600 million valuation, led by Elad Gil, to expand security infrastructure for AI agents.
Vera Health Raises $28.5M Series A for Clinical AI Search
Vera Health raised a $28.5 million Series A led by Threshold Ventures to further develop its clinical evidence infrastructure and expand into additional healthcare markets.
Omnichat Raises US$10M Series A for Agentic Customer Experience Platform
Omnichat raised a US$10 million Series A led by Openspace Capital to scale its agentic AI platform, deepen R&D on Omni AI Agents and expand globally.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free